Related references
Note: Only part of the references are listed.Respiratory Capacity and Reserve Predict Cell Sensitivity to Mitochondria Inhibitors: Mechanism-Based Markers to Identify Metformin-Responsive Cancers
Jing Tsong Teh et al.
MOLECULAR CANCER THERAPEUTICS (2019)
OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ
Zhengkui Zhang et al.
MOLECULAR CELL (2019)
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
Matthew R. Janes et al.
CELL (2018)
The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell
Steven W. Plouffe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways
Yulei Zhao et al.
MOLECULAR CANCER RESEARCH (2018)
Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells
Hisham F. Bahmad et al.
FRONTIERS IN ONCOLOGY (2018)
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Marta Prieto-Vila et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer
Kanjoormana Aryan Manu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Isoprenylcysteine carboxylmethyltransferase function is essential for RAB4A-mediated integrin β3 recycling, cell migration and cancer metastasis
M. T. Do et al.
ONCOGENE (2017)
Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms
H. Y. Lau et al.
ONCOGENE (2017)
A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer
Xiao Zhao et al.
CANCER LETTERS (2017)
Eradicating tumor drug resistance at its YAP-biomechanical roots
Francesca Zanconato et al.
EMBO JOURNAL (2016)
YAP overexpression promotes the epithelial-mesenchymal transition and chemoresistance in pancreatic cancer cells
Yanli Yuan et al.
MOLECULAR MEDICINE REPORTS (2016)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
Protein prenylation: unique fats make their mark on biology
Mei Wang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer
Sameerah Shaheen et al.
STEM CELL REVIEWS AND REPORTS (2016)
Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer
Sameerah Shaheen et al.
STEM CELL REVIEWS AND REPORTS (2016)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin et al.
NATURE GENETICS (2015)
Oncogenic K-Ras promotes proliferation in quiescent intestinal stem cells
Jessica J. Gierut et al.
STEM CELL RESEARCH (2015)
Activated K-Ras, but Not H-Ras or N-Ras, Regulates Brain Neural Stem Cell Proliferation in a Raf/Rb-Dependent Manner
R. Hugh F. Bender et al.
STEM CELLS (2015)
NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition
Maria E. R. Garcia-Rendueles et al.
CANCER DISCOVERY (2015)
Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism
J. T. Teh et al.
ONCOGENE (2015)
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
M. Bartucci et al.
ONCOGENE (2015)
An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo
Hiu Yeung Lau et al.
CANCER BIOLOGY & THERAPY (2014)
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Avnish Kapoor et al.
CELL (2014)
KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
Diane D. Shao et al.
CELL (2014)
Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
Yasmine Touil et al.
CLINICAL CANCER RESEARCH (2014)
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
Xaralabos Varelas
DEVELOPMENT (2014)
Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover
Xin Hong et al.
EMBO JOURNAL (2014)
The Hippo signaling pathway in stem cell biology and cancer
Jung-Soon Mo et al.
EMBO REPORTS (2014)
Pluripotent Stem Cell miRNAs and Metastasis in Invasive Breast Cancer (vol 106, dju324, 2014)
Stefano Volinia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Randy Johnson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
Weiying Zhang et al.
SCIENCE SIGNALING (2014)
Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer
Niranjan Awasthi et al.
CARCINOGENESIS (2013)
Regulation of Hippo Signaling by EGFR-MAPK Signaling through Ajuba Family Proteins
B. V. V. G. Reddy et al.
DEVELOPMENTAL CELL (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine
Anke Van den Broeck et al.
BMC CANCER (2012)
The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCFβ-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition
Wei Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cancer stem cell definitions and terminology: the devil is in the details
Peter Valent et al.
NATURE REVIEWS CANCER (2012)
Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
Dulcie Lai et al.
CANCER RESEARCH (2011)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
The Sterile 20-like Kinase Tao-1 Controls Tissue Growth by Regulating the Salvador-Warts-Hippo Pathway
Carole L. C. Poon et al.
DEVELOPMENTAL CELL (2011)
Tao-1 Phosphorylates Hippo/MST Kinases to Regulate the Hippo-Salvador-Warts Tumor Suppressor Pathway
Julian C. Boggiano et al.
DEVELOPMENTAL CELL (2011)
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
Krishna P. L. Bhat et al.
GENES & DEVELOPMENT (2011)
A Role for Rac3 GTPase in the Regulation of Autophagy
Wan Long Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
TAZ is a novel oncogene in non-small cell lung cancer
Z. Zhou et al.
ONCOGENE (2011)
Multicellular tumor spheroids: An underestimated tool is catching up again
Franziska Hirschhaeuser et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
Anna Maria Calcagno et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth
M. Wang et al.
ONCOGENE (2010)
Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells
C. S. Pichot et al.
BRITISH JOURNAL OF CANCER (2009)
WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics
Isabelle Bisson et al.
CELL RESEARCH (2009)
Role of Isoprenylcysteine Carboxylmethyltransferase-catalyzed Methylation in Rho Function and Migration
Ian Cushman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
Robert H. Kutner et al.
NATURE PROTOCOLS (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells
Siew Wee Chan et al.
CANCER RESEARCH (2008)
A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells
Mei Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
Integrative genomic approaches identify IKBKE as a breast cancer oncogene
Jesse S. Boehm et al.
CELL (2007)
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
D Ponti et al.
CANCER RESEARCH (2005)
Opinion - Post-prenylation-processing enzymes as new targets in oncogenesis
AM Winter-Vann et al.
NATURE REVIEWS CANCER (2005)
A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells
AM Winter-Vann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Isolation of cancer stem cells from adult glioblastoma multiforme
XP Yuan et al.
ONCOGENE (2004)
Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis
L Vitale-Cross et al.
CANCER RESEARCH (2004)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase
A McFall et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells
MO Bergo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
